Healthcare provider profile · identity verified

Nissy Philip

Internal Medicine · KANSAS CITY, MO · NPI 1356886089

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	340	99
Amlodipine Besylate	Amlodipine Besylate	239	76
Gabapentin	Gabapentin	189	51
Metformin Hcl	Metformin Hcl	179	48
Losartan Potassium	Losartan Potassium	161	45
Albuterol Sulfate Hfa	Albuterol Sulfate	143	48
Lisinopril	Lisinopril	143	43
Fluticasone Propionate	Fluticasone Propionate	140	40
Rosuvastatin Calcium	Rosuvastatin Calcium	133	35
Pantoprazole Sodium	Pantoprazole Sodium	127	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	104	35
Carvedilol	Carvedilol	100	35
Hydrochlorothiazide	Hydrochlorothiazide	89	32
Famotidine	Famotidine	86	23
Potassium Chloride	Potassium Chloride	75	23
Furosemide	Furosemide	68	25
Levothyroxine Sodium	Levothyroxine Sodium	67	19
Metoprolol Succinate	Metoprolol Succinate	67	19
Chlorthalidone	Chlorthalidone	63	17
Sertraline Hcl	Sertraline Hcl	60	13
Spironolactone	Spironolactone	60	18
Baclofen	Baclofen	59	23
Tamsulosin Hcl	Tamsulosin Hcl	58	18
Pravastatin Sodium	Pravastatin Sodium	51	13
Pregabalin	Pregabalin	50	11
Clopidogrel	Clopidogrel Bisulfate	48	12
Metformin Hcl Er	Metformin Hcl	47	13
Montelukast Sodium	Montelukast Sodium	47	12
Omeprazole	Omeprazole	47	20
Lidocaine	Lidocaine	43	15
Symbicort	Budesonide/Formoterol Fumarate	43	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Meloxicam	Meloxicam	40	12
Diclofenac Sodium	Diclofenac Sodium	37	17
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Ibuprofen	Ibuprofen	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Xarelto	Rivaroxaban	32	11
Jardiance	Empagliflozin	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	12
Trulicity	Dulaglutide	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Naproxen	Naproxen	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Simvastatin	Simvastatin	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Eliquis	Apixaban	21	suppressed
Felodipine Er	Felodipine	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Ozempic	Semaglutide	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Glipizide	Glipizide	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lyrica	Pregabalin	13	suppressed
Allopurinol	Allopurinol	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Nyamyc	Nystatin	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error